Skip to main content
Quest Diagnostics Home.

Covid-19測試價格信息

When billed to health plans or the government\r\n","@type":"corporate/components/text"}}" id="text-f018789e59" class="cmp-text">

When billed to health plans or the government

\r\nTest Name\r\nDescription\r\nCPT/HCPC Codesa\r\nPrice\r\nCase Price/Cost\r\nSARS-CoV-2 RNA (COVID-19), Qualitative NAATb\r\nThe test is designed to detect the virus that causes COVID-19 in respiratory specimens, for example, nasal or oral swabs.\r\nU0003
\r\nU0005 (when applicable)\r\nQuest will bill your health plan or the government $100.00 or $125.00 depending on the plan\r\nZero out-of-pocket patient responsibility is expected for medically appropriate testing ordered by an authorized provider when billed to a health plan or the government\r\nSARS-CoV-2 Antibody (IgG), Spike, Semi-Quantitative test\r\nThis test may detect an immune response to a prior or recent infection with SARS-CoV-2 (COVID-19).
\r\n
\r\n\r\n86769\r\nQuest will bill your health plan or the government $55.00c
\r\n
\r\n\r\nZero out-of-pocket patient responsibility is expected for medically appropriate testing ordered by an authorized provider when billed to a health plan or the government\r\nSARS-CoV-2 Serology (COVID-19) Antibodies (IgG, IgM), Immunoassay\r\nThe test is designed to detect IgG and IgM antibodies in a blood sample that may indicate exposure to COVID-19. IgM antibodies to COVID-19 are generally detectable in blood several days after initial infection, with IgG antibodies typically reaching detectable levels simultaneously or 1-2 days later.
\r\n
\r\n\r\n86769 x2
\r\n
\r\n\r\nQuest will bill your health plan $110.00c\r\nZero out-of-pocket patient responsibility is expected for medically appropriate testing ordered by an authorized provider when billed to a health plan or the government\r\nSARS-CoV-2 RNA (COVID-19) and Influenza A and B, Qualitative NAAT\r\nThis is a qualitative multi-target molecular diagnostics test that aids in simultaneous detection of COVID-19, influenza A and influenza B.
\r\n
\r\n\r\n87636 (1)
\r\n
\r\n\r\nQuest will bill your health plan $511.70c\r\nZero out-of-pocket patient responsibility is expected for medically appropriate testing ordered by an authorized provider when billed to a health plan or the government\r\nSARS-CoV-2 RNA (COVID-19), Influenza A/B, and RSV RNA, Qualitative NAAT\r\nThis is a multitarget molecular test that aids in simultaneous qualitative detection and differentiation of COVID-19, influenza A, influenza B, and respiratory syncytial virus (RSV) viral RNA among symptomatic patients.\r\n0241U\r\nQuest will bill your health plan $925.65c\r\nZero out-of-pocket patient responsibility is expected for medically appropriate testing ordered by an authorized provider when billed to a health plan or the government\r\n\r\n","@type":"corporate/components/text"}}" id="text-1a5e382ca0" class="cmp-text">
Test Name Description CPT/HCPC Codes一種 價錢 Case Price/Cost
SARS-COV-2 RNA(Covid-19),定性NaatB. 該測試旨在檢測導致呼吸樣本中的Covid-19的病毒,例如鼻腔或口服拭子。 U0003
U0005 (when applicable)
任務將根據計劃票據或政府收費100.00美元或125.00美元 預計授權提供商在向健康計劃或政府訂購時,預計零袋患者責任預計會有授權提供商訂購的測試
SARS-COV-2抗體(IgG),尖峰,半定量測試 該測試可以檢測對SARS-COV-2(Covid-19)的先前或最近感染的免疫應答。

86769. 任務將為您的健康計劃或政府收費55.00美元C

預計授權提供商在向健康計劃或政府訂購時,預計零袋患者責任預計會有授權提供商訂購的測試
SARS-COV-2血清學(Covid-19)抗體(IgG,IgM),免疫測定 該測試設計用於檢測血液樣品中的IgG和IgM抗體,其可能表示暴露於Covid-19。在初始感染後幾天通常可檢測到Covid-19的IgM抗體在初始感染後幾天,IgG抗體通常同時達到可檢測水平或後1-2天。

86769.x2

Quest將為您的健康計劃收取110.00美元C 預計授權提供商在向健康計劃或政府訂購時,預計零袋患者責任預計會有授權提供商訂購的測試
SARS-COV-2 RNA(Covid-19)和流感A和B,定性Naat This is a qualitative multi-target molecular diagnostics test that aids in simultaneous detection of COVID-19, influenza A and influenza B.

87636(1)

Quest will bill your health plan $511.70C 預計授權提供商在向健康計劃或政府訂購時,預計零袋患者責任預計會有授權提供商訂購的測試
SARS-COV-2 RNA(Covid-19),流感A / B和RSV RNA,定性Naat 這是一種多元分子試驗,有助於在症狀患者中同時進行Covid-19,流感A,流感病毒(RSV)病毒RNA的同時定性檢測和分化。 0241U. Quest將為您的健康計劃收取925.65美元C 預計授權提供商在向健康計劃或政府訂購時,預計零袋患者責任預計會有授權提供商訂購的測試
When patient pays out-of-pocket through QuestDirect
\r\n\r\n","@type":"corporate/components/text"}}" id="text-b300870c67" class="cmp-text">

當患者通過QuestDirect支付出口時

\r\nTest Name
\r\n\r\nDescription\r\nCPT/HCPCS Codesa\r\nPrice*\r\nCash Price/Cost\r\nCOVID-19 Active Infection\r\nThe test is designed to detect the virus that causes COVID-19 in respiratory specimens. This test is for individuals who decide to pay out-of-pocket for the test and do not wish to have their claims submitted for reimbursement to their health plan or the government.\r\nNA\r\nTotal Patient Cash Price/Cost: $125.00*

 

\r\n

 

\r\n*Pricing is comprised of $119.00 for testing and conveyance of results, plus $6.00 for electronic order review by an authorized third-party provider\r\n$125.00\r\nCOVID-19 and Flu Test\r\nThis is a qualitative multi-target molecular diagnostics test that aids in simultaneous detection of COVID-19, influenza A and influenza B.\r\nNA\r\n

Total Patient Cash Price/Cost: $205.00* 

\r\n

 

\r\n

*Pricing is comprised of $199.00 for testing and conveyance of results, plus $6.00 for independent physician oversight of lab testing including ordering testing if appropriate, and providing physician follow-up services

\r\n\r\n$205.00\r\nCOVID-19 Antibody Test\r\nThe test is designed to detect antibodies in a blood sample that would indicate that a patient may have had a prior or recent COVID-19 infection. This test is for individuals who decide to pay out-of-pocket for the test and do not wish to have their claims submitted for reimbursement to their health plan or the government.\r\nNA\r\nTotal Patient Cash Price/Cost: $75.00*

 

\r\n

 

\r\n*Pricing is comprised of $69.00 for testing and conveyance of results, plus $6.00 for independent physician oversight of lab testing including ordering testing if appropriate, and providing physician follow-up services\r\n$75.00\r\nCOVID-19 At-Home Rapid Antigen Test (2-pack)\r\nThis at-home rapid antigen test includes supervision by a telehealth proctor at eMed Lab, LLC.\r\n87426\r\nTotal Patient Cash Price/Cost: $70

 

\r\n\r\n$70.00\r\n\r\n","@type":"corporate/components/text"}}" id="text-efbd9a4680" class="cmp-text">
Test Name
Description CPT / HCPCS代碼一種 價錢* 現金價格/費用
Covid-19活性感染 The test is designed to detect the virus that causes COVID-19 in respiratory specimens. This test is for individuals who decide to pay out-of-pocket for the test and do not wish to have their claims submitted for reimbursement to their health plan or the government. 總計患者現金價格/費用:125.00美元*

*Pricing is comprised of $119.00 for testing and conveyance of results, plus $6.00 for electronic order review by an authorized third-party provider
$ 125.00
Covid-19和流感測試 This is a qualitative multi-target molecular diagnostics test that aids in simultaneous detection of COVID-19, influenza A and influenza B.

Total Patient Cash Price/Cost: $205.00*

*定價由199.00美元組成,用於測試和運輸結果,以及6.00美元,用於實驗室測試的獨立醫生監督,包括合適的訂購測試,並提供醫師隨訪服務

$205.00
Covid-19抗體測試 該測試旨在檢測血液樣本中的抗體,表示患者可能具有先前或最近的Covid-19感染。該測試是針對決定支付考試的個人的個人,不希望將其索賠提交給其衛生計劃或政府的償還。 總計現金價格/費用:75.00美元*

*定價由69.00美元組成,用於測試和運輸結果,以及6.00美元的獨立醫生監督實驗室測試,包括適當的訂購測試,並提供醫師隨訪服務
$ 75.00
Covid-19在家中快速抗原測試(2包) 這個在家中快速抗原測試包括由EMED Lab,LLC的遠程醫療Proctor的監督。 87426 Total Patient Cash Price/Cost: $70

$70.00

一種The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

B.This test is also offered as part of two additional testing panels: a) SARS-CoV-2 RNA (COVID-19) and Respiratory Viral Panel, Qualitative NAAT; b) SARS-CoV-2 RNA (COVID-19) and Respiratory Pathogen Panel, Qualitative NAAT.

C付款人支付的金額可能因承保和承包利率而有所不同。

COVID-19 testing statements

  • 抗體試驗,分子試驗和抗原試驗(一起“所有測試”)尚未被FDA清除或批準;
  • 所有測試已由FDA授權歐盟以授權實驗室使用;
  • 抗體試驗僅授權用於檢測針對SARS-COV-2的IgG抗體,而不是任何其他病毒或病原體;
  • Covid-19的分子試驗已被授權僅用於從SARS-COV-2檢測核酸,而不是任何其他病毒或病原體;
  • The COVID-19 and flu panel test has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acid from SARS-CoV-2, influenza A virus, and influenza B virus, and not for any other viruses or pathogens; and
  • Covid-19,流感和RSV麵板測試僅用於來自SARS-COV-2,流感A,流感B和呼吸道合胞病毒(RSV)的同時定性檢測和分化,而不是任何其他物理病毒或病原體;
  • 抗原試驗已被授權用於檢測來自SARS-COV-2的蛋白質,而不是任何其他病症或病原體;和
  • All tests are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

關於FDA緊急使用授權(EUA)狀態

該測試已由FDA授權在緊急使用授權(EUA)下。這意味著,雖然Quest Diagnostics已驗證測試並具有數據以相信測試和收集套件準確,但該測試尚未被FDA清除或批準;該測試已由FDA授權,以授權實驗室使用的EUA;該試驗僅用於檢測針對SARS-COV-2的IgG抗體,而不是任何其他病症或病原體;並且,該測試僅授權宣布的持續時間,即在第564(b)(b)(b)(b)(b)(b)(b)(b)(b)(1)條第21條第564(b)(b)(b)(b)(b)(1)條第564(b)(b)(b)(1)條第564(b)(b)(1)條第564(b)(b)(b)(b)(b)(1)條第564(b)(b)(b)(b)(1)條第564(b)(b)(b)(b)(1)條第564(B)(1)條第564(B)(1)條的情況下授權授權。U.S.C. § 360BBB-3(B)(1), unless the authorization is terminated or revoked sooner. Additional studies need to be conducted for this test and others like it to be FDA cleared or approved.

Baidu
map